Develop Drugs, Not Duds: Strategies for In Vivo Drug Research Success

Are you validating your targets and nearing in vivo research? This phase requires insightful and thorough planning to continue your drug or biotherapeutic down the drug development pipeline. Without a clear approach, your timelines can be significantly delayed and all the effort it has taken to get here may be compromised.

Join us for lunch on Wednesday May 21 as Charles River scientist, Manu Kohli, PhD, presents an interactive overview of effective in vivo strategies to avoid common pitfalls in nonclinical development.

Key learnings will include:
– Effectively assessing efficacy and mechanism of action, drug exposure, and safety
– How to reduce risks and time loss due to common pitfalls
– Strategies for selecting or generating the right in vivo pharmacology models
– How to prepare today for key objectives of future regulatory submissions
– Supporting the 3Rs for pharmacology and safety assessment

Lunch will be provided, and you’ll have the opportunity to network with our speakers and tour the on-site Charles River Accelerator and Development Lab (CRADL®), which offers rentable, turnkey vivarium lab space and services for your research.